To determine variability and agreement for detecting myocardial edema with T2-weighted short-tau inversion recovery (STIR), acquisition for cardiac unified T2 edema (ACUT2E), T2 mapping, and early gadolinium enhancement (EGE) after successfully reperfused ST-segment-elevation myocardial infarction (STEMI) and diagnostic accuracy of each sequence to predict infarct-related artery (IRA).
T he detection and quantification of myocardial edema by using cardiovascular magnetic resonance (MR) imaging (cardiac MR) is transforming the understanding of acute myocardial infarction because the myocardium at risk and myocardial salvage (myocardial edema or myocardium at risk minus infarct size) can now be identified and measured noninvasively (1) (2) (3) .
In clinical practice, detection of myocardial edema can allow the identification of the infarct-related artery (IRA) and guide management. In the scientific setting, the quantification of myocardial salvage with reperfusion and adjuvant strategies of myocardial infarction can act as surrogate end points in clinical trials (4) . Therefore, the precision and the robustness (agreement and variability) of the method used to assess myocardial edema are pivotal. Abbreviations: ACUT2E = acquisition for cardiac unified T2 edema EGE = early gadolinium enhancement ICC = intraclass correlation coefficient IRA = infarct-related artery SD = standard deviation STEMI = ST-segment-elevation myocardial infarction STIR = short-tau inversion recovery
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Advances in Knowledge
n With this comparison, EGE (1 2 ICC = 0.03) and T2 mapping (1 2 ICC = 0.05) have a similar low intraobserver variability.
n Overall, among the four sequences tested and taking into account the three variability parameters (intraobserver, interobserver, and interimage), T2 mapping is the most reproducible method for detecting myocardial edema following reperfused STsegment-elevation myocardial infarction (STEMI).
Implication for Patient Care
n In this study, we determined that, of the four sequences tested, the prediction of the infarct-related artery (IRA) territory with T2 mapping and EGE most closely matches the depiction of the IRA territory with angiography following STEMI (98% patients with T2 mapping, 95% patients with EGE).
Currently, the most widely used technique is the T2-weighted short-tau inversion-recovery (STIR) method (5), which also demonstrates prognostic value (6) . However, recent technical innovations have introduced alternative methods that may have potential advantages and translate to improved diagnostic precision and robustness. These are T2 mapping (7); acquisition for cardiac unified T2 edema (ACUT2E) (8), a turbo spin-echo steady-state free precession hybrid bright-blood sequence; and imaging early (1-3 minutes) after gadolinium-based contrast agent administration (early gadolinium enhancement [EGE]) (9) . However, the experience in using these in the above setting is limited.
The hypothesis of the study was that one of the newer sequences would have reproducibility superior to that of T2-weighted STIR. The purpose of the study was to determine the intraobserver, interobserver, and interimage variability and the agreement for four methods available for detecting myocardial edema (T2-weighted STIR, ACUT2E, T2 mapping, and EGE) in patients after successfully reperfused STsegment-elevation myocardial infarction (STEMI). In addition, we aimed to determine the diagnostic accuracy of each sequence to predict the IRA.
Materials and Methods
The ACUT2E and T2 mapping sequences were supplied as work-inprogress packages by Siemens Healthcare (Frimley, England). The authors (E.J.M., C.B.) who are not employees of Siemens Healthcare (Frimley, England) had control of inclusion of any data and information that might present a conflict of interest for the author (P.J.W.) who is an employee of or a consultant for Siemens Healthcare (Frimley, England).
Patient Population
Consecutive patients with the first myocardial infarction on day 2 after successful primary angioplasty for STEMI were enrolled in the study to minimize referral bias, and these patients reflected clinical practice. Successful primary angioplasty was defined as a final Thrombolysis in Myocardial Infarction, or TIMI, flow grade 3 in the IRA.
Inclusion criteria were (a) patients presenting with STEMI who (b) proceeded with primary percutaneous coronary intervention within 12 hours of pain. Patients were excluded if they had contraindications to MR imaging (two patients), chronic atrial fibrillation (one patient), renal impairment with estimated glomerular filtration rate of less than 30 mL/min/1.73 m 2 , or cardiogenic shock (two patients).
The study was approved by the local ethics committee, and all patients 
Cardiac MR Protocol
The images were acquired by using a 1.5-T MR imaging system (Magnetom Avanto; Siemens Healthcare, Erlangen, Germany) with a standard 12-channel matrix coil configuration. All images were acquired by the same operator (E.J.M., level 3 Society for Cardiovascular Magnetic Resonance-European Society of Cardiology accredited with more than 3 years of cardiac MR experience). Two cardiac MR imaging examinations (image set A and image set B) were performed in each patient on the same day, at least 6 hours apart. In five patients, T1 and T2 mapping nonenhanced images were acquired in both image set A and image set B to demonstrate that images in image set B were unaffected by residual contrast agent from image set A.
Each image set consisted of three long-axis (four-, three-, and twochamber view) and a full stack of short-axis steady-state free precession cine images. This was followed by the acquisition of three short-axis sections (basal, midcavity, and apical) by using T2-weighted STIR, T2 mapping, and ACUT2E sequences. Subsequently, acquisition of the same three short-axis sections (basal, midcavity, and apical) was repeated by using a segmented inversion-recovery gradient-echo sequence 1-3 minutes after the intravenous administration of 0.1 mL/kg of gadobutrol (Gadovist; Bayer Schering Pharma, BerlinWedding, Germany) (EGE). Finally, late gadolinium enhancement images were acquired 15-20 minutes after contrast agent injection in the three long-axis and the full stack of shortaxis views.
All sequence parameters are illustrated in Table 1 , and the corresponding images obtained with the sequences are presented in Figure 1 .
To ensure matching of section position among all four sequences, the same acquisition planes were adopted. To maintain the closest anatomic position of the three sections between image set A and image set B, the position relative to the mitral valve plane was measured and copied as a reference for image set B. The same field of view and section thickness were used for all sequences. Each section was obtained during a breath hold of 10-15 seconds depending on the patient's heart rate.
T2-weighted STIR Sequence
For T2-weighted STIR imaging, a breath-hold black-blood segmented turbo spin-echo technique (10) was adopted, with use of a triple inversion-recovery preparation module to suppress signal from flowing blood, as well as from fat, with surface coil normalization. Typically, parameters were as follows: repetition time, two R-R intervals; echo time, 75 msec; flip angle, 90°; inversion time, 170 msec; section thickness, 8 mm; field of view, 340-400 mm; matrix, 208 3 256; and voxel size, 2.3 3 1.4 3 8 mm. T2-weighted STIR images were acquired during six to eight consecutive breath holds.
ACUT2E Sequence
The ACUT2E sequence is a turbo spin-echo steady-state free precession pulse sequence that does not require a black-blood preparation or a T2 preparation (8) . Typical parameters used were as follows: repetition time msec/echo time msec, 233.23/1.84; flip angle, 180°; section thickness, 8 mm; matrix, 210 3 256; and voxel size, 1.4 3 1.4 3 8 mm, with an optimized coil sensitivity correction method.
T2 Mapping Sequence
The T2 mapping sequence (7) consisted of a T2 prepared steady-state free precession sequence that generates three T2-weighted images, each with its own T2 preparation time (0, 24, and 55 msec). These images are acquired in the transient state of single-shot steady-state free precession immediately after the T2 preparation pulse. The signal intensity in each image represents a different echo time along the T2 decay curve. The sequence is performed during seven heartbeats with two R-R intervals to allow for T1 recovery. 
EGE Sequence
The EGE images were acquired with an inversion-recovery prepared breath-hold gradient-echo sequence 1-3 minutes after contrast agent injection, in keeping with the literature (9) . Typical image parameters were as follows: 700/3.17; matrix, 208 3 256; flip angle, 25°; section thickness, 8.0 mm; and voxel size, 1.9 3 1.4 3 8 mm, with coil normalization. The inversion time was progressively optimized to null normal myocardium (typical values, 200-250 msec).
Image Analysis
All images (three short-axis sections, four sequences, two imaging examinations) were randomized per sequence type and analyzed independently by two observers (E.J.M. and C.B., both of whom were level 3 Society for Cardiovascular Magnetic Resonance-European Society of Cardiology accredited with more than 3 years of cardiac MR experience) who were blinded to clinical and angiographic data. When present, areas of microvascular obstruction and hemorrhage were included within the area contoured for edema. The data set included 480 (40 3 12) images for image set A and 480 images for image set B. For intraobserver variability, observer 1 analyzed image set A and reanalyzed image set A at an interval of 1 month. For interobserver variability, both observer 1 and observer 2 analyzed image set A. For interimage variability, observer 1 analyzed image set A and image set B. Therefore, a total of 1920 images were analyzed. To ensure consensus agreement on the affected territories, the hyperintense zones were first reviewed by two observers with more than 3 years of experience in cardiac MR imaging (E.J.M., C.B.) who were blinded to clinical and angiographic data.
Myocardial edema quantitative analyses were performed by manually measuring the area of abnormal signal intensity with a planimeter by using commercially available semiautomated software (Argus; Siemens Healthcare, Erlangen, Germany) and expressing the measurement in grams (assuming a specific gravity of 1.05 g/mL). For T2-weighted STIR and ACUT2E, the optimal window setting was defined as the sum of the mean myocardial signal intensity of the unaffected area plus 2 standard deviations (SDs) for this area. The level setting was set at the mean signal intensity of the unaffected area (11) . For T2 mapping and EGE, the window setting was visually optimized, according to data in previous literature (9, 12) .
Statistical Analysis
For each of the four sequences, intraobserver, interobserver, and interimage agreement were assessed by using the Bland-Altman 95% limits of agreement method (13) as follows: means and SDs of the differences between repeat measurements and 95% limits of agreement, calculated as M 6 (1.96 · SD), where M is the mean, were calculated. Bland-Altman plots of the difference between the measurements compared with their mean were constructed. Differences in myocardial edema size among all four sequences were assessed between the sequences and the reference standard of T2-weighted STIR by using the paired t test. T1 and T2 values (nonparametric data) were assessed by using the Wilcoxon matched-pairs test. The variability data were graphically displayed, showing the variability attributed to intraobserver, interobserver, and interimage effects as a proportion of total variability for each method (1 2 intraclass correlation coefficient [ICC]) (14) . The difference between each sequence to detect the IRA was assessed by using an unadjusted Fisher exact test. The difference between the ages of male and female patients was assessed by using an unpaired t test.
Of the 53 patients initially enrolled, 40 completed the protocol successfully (three sections obtained, four sequences performed, and two imaging examinations performed). Table 2 Baseline Characteristics
Characteristic Value
Mean age 6 SD (y) 60 6 Thirteen patients (25%) withdrew following the first imaging examination because of claustrophobia (11 patients), fatigue (one patient), or inability to continue with the second imaging examination (one patient). The median time difference between the two imaging examinations was 7 hours (range, 7-10 hours). Eighty percent of patients were male, and 20% were female. The difference between the ages of the male and female patients was significant (P = .004): The mean age for male patients was 57 years (range, 38-79 years), and the mean age for female patients was 70 years (range, 51-80 years). The baseline characteristics of the patients are listed in Table 2 .
Results

Size of Myocardial Edema and Myocardium at Risk
The mean size of myocardial edema ranged from 14.0 to 18.2 g (observer 1) among all sequences. T2-weighted STIR was used as the reference standard for myocardial edema mass comparison, as this sequence has the most evidence behind its use and, more important, has prognostic data (6,15,16). T2-weighted STIR produced the largest mass of edema, with a 5% reduction when assessed with T2 mapping, a 23% reduction when assessed with ACUT2E, and a 22% reduction when assessed with EGE (Table 3) . There was a significant difference between T2-weighted STIR (mean, 18.2 g) and ACUT2E (mean, 14.0 g) (P = .01) and between T2-weighted STIR (mean, 18.2 g) and EGE (mean, 14.2 g) (P = .003). The size of myocardium at risk was similar between T2-weighted STIR (mean, 18.2 g) and T2 mapping (mean, 17.3 g) (P = .54). After allowing for multiple testing, the differences between T2-weighted STIR and ACUT2E and T2-weighted STIR and EGE remained significant.
Sequence Agreement
Agreement was assessed by using the Bland-Altman method. BlandAltman plots for interobserver ( Fig  E1 [online] ), intraobserver ( Fig E2  [online] ), and interimage (Fig E3 [online] ) agreement demonstrated that all sequences had a low bias. However, there is a small but consistent systematic difference between observers for interobserver agreement for all sequences except T2-weighted STIR (Fig E1 [online] ). T2 mapping had consistently tight limits of agreement.
For interobserver agreement, T2-weighted STIR had a bias of 20.9 (mean difference) 6 9.6 (SD), ACUT2E had a bias of 22.5 6 6.9, T2 mapping had a bias of 23.8 6 4.7, and EGE had a bias of 25.3 6 5.9. For interimage agreement, T2-weighted STIR had a bias of 1.5 6 5.8, ACUT2E had a bias of 20.8 6 4.9, T2 mapping had a bias of 3.1 6 4.0, and EGE had a bias of 1.1 6 4.9. For intraobserver agreement, T2-weighted STIR had a bias of 1.4 6 5.8, ACUT2E had a bias of 0.6 6 4.7, T2 mapping had a bias of 2.2 6 3.1, and EGE had a bias of 1.7 6 2.9.
Myocardial Edema Variability
Variability was determined as 1 minus the ICC for assessing myocardial edema and is shown in Figure 2 . Compared with any other technique and by taking into account interobserver, intraobserver, and interimage variability, T2 mapping had the lowest variability overall. However, EGE had the lowest intraobserver variability. For T2 mapping, 1 minus ICC was 0.05 for intraobserver variability; that for interobserver variability was 0.09, and that for interimage variability was 0.1. For EGE, 1 minus ICC was 0.03 for intraobserver variability; that for interobserver variability was 0.14; and that for interimage variability was 0.14. For ACUT2E, 1 minus ICC was 0.11 for intraobserver variability; that for interobserver variability was 0.22; and that for interimage variability was 0.12. For T2-weighted STIR, 1 minus ICC was 0.1 for intraobserver variability; that for interobserver variability was 0.32; and that for interimage variability was 0.1. Interimage T1 and T2 Readings To demonstrate that there was no residual effect on T1 or T2 values on image set B from the gadolinium-based contrast agent delivered during acquisition of image set A, that is, that the more than 6-hour delay chosen between the two imaging examinations was appropriate to allow for contrast agent elimination, T1 and T2 mapping sequences were used to generate T1 and T2 values of the edematous myocardium and remote myocardium. With use of T1 mapping, there was no significant difference between the T1 readings for remote myocardium (image set A, 1141 msec; image set B, 1100 msec; P = .81) and edematous myocardium (image set A, 964 msec, image set B, 924 msec; P = .19) between image set A and image set B (Fig 3) . Similarly, there was no significant difference between T2 values for the edematous area (image set A, 71 msec; image set B, 71 msec; P = .72) or remote myocardium (image set A, 54 msec; image set B, 53 msec; P = .09) between image set A and image set B.
Detection of IRA Territory
For the purposes of analysis, IRAs were assigned to a territory according to standardized myocardial segmentation (17): the anteroseptum and anterior wall were assigned to the left anterior descending artery territory, the lateral wall was assigned to the left circumflex artery territory, and the inferior wall and inferoseptum were assigned to the right coronary artery territory (17) . Many patients had a large amount of myocardial salvage (minimal late gadolinium enhancement) from early intervention.
In using myocardial edema for the identification of IRA, the edema segments with T2 mapping closely matched IRA determined by using angiography (98% of patients [39 of 40]) compared with EGE (95% of patients [38 of 40]), ACUT2E (88% of patients [35 of 40]), and, last, T2-weighted STIR (82% of patients [33 of 40]). However, this result was not significant at a .05 cutoff (P = .1). A case example in a patient is illustrated in Figure 4 .
Image Quality
Image quality was subjectively visually graded as 1 or 2 (grade 1, good; grade 2, suboptimal or nondiagnostic). Images were suboptimal or nondiagnostic if there was artifact or signal loss that interfered with the ability of the observers to interpret the image. The overall image quality was good for all sequences. However, Figure 4 Figure 4: Case example. Basal short-axis sections obtained in a 63-year-old man with a right coronary artery territory acute myocardial infarction by using (a) T2-weighted STIR, (b) T2 mapping, (c) ACUT2E, and (d) EGE. Myocardial edema (outlined area) is well demarcated on T2 mapping and EGE images, while the borders are less clear on T2-weighted STIR and ACUT2E images, with implication in the precision of contouring.
it was reported by the two observers (100% agreement) as suboptimal in 5% of cases for the T2-weighted STIR images and in 3% of cases for the ACUT2E images. Both the T2 mapping and EGE images provided good and interpretable image quality in 100% of patients.
Discussion
Comparison of the four edema detection methods (T2-weighted STIR, ACUT2E, T2 mapping, EGE) after infarction and their variability has not previously been well established in the literature. Our most important finding was that T2 mapping has a low variability and good agreement over other methods for edema detection, with improved qualitative detection of myocardium at risk when compared with the IRA detected at angiography. This study has shown for the first time the interstudy reproducibility of these four techniques. As the reproducibility squared determines power calculations, using the more reproducible technique, the number needed in trials is smaller. This may have important implications for clinical trials in which myocardium at risk or myocardial salvage is used as a surrogate end point, given the effect of this outcome precision and assessment on trial design and results.
Opportunities and Limitations of T2-weighted STIR Currently, T2-weighted STIR is the most commonly used method to assess the presence and extent of myocardial edema both in clinical practice (18) and in clinical trials and outcome studies (19, 20) . In clinical practice, T2-weighted STIR has been proven to be useful in differentiating acute from chronic infarcts (21, 22) , as well as acute from chronic phase of inflammatory myocardial disease (23), providing valuable clinical information that can guide treatment. In the setting of clinical trials, T2-weighted STIR has been consistently used to measure myocardium at risk and myocardial salvage (4, 20) following different reperfusion strategies. Although T2-weighted STIR is validated (2, 24) and established in clinical practice, it has many limitations, and researchers in recent studies have developed newer methods that may be more reproducible (7, 8, 25) . However, while researchers in previous studies investigated the head-to-head comparison of two sequences, in our study, we compared four sequences.
From the literature (26, 27) , the main limitations of T2-weighted STIR include the following: (a) not very sharp images (relatively low signal-to-noise ratio and relatively small contrast-tonoise ratio between normal and affected myocardium); (b) images with false-negative findings that could be avoided with surface coil intensity correction, which we used in this study; (c) images with false-positive findings, caused by incomplete dark blood preparation, that can lead to bright rim blood artifact adjacent to the endocardium; and (d) artifacts and incomplete images (susceptibility to through-plane cardiac motion with potential myocardial signal loss). These limitations can lead to inaccuracy in the assessment and measurement of myocardial edema or salvage, and this is a particularly important issue when considering using myocardial edema as a surrogate end point in clinical trials (4) . In fact, in this setting, it is pivotal to have a parameter that is robustly measurable and reproducible. In our study, T2-weighted STIR images were suboptimal in 5% of the patients (n = 2), and this result was caused by artifacts due to ectopic beats in one patient and signal loss due 
Opportunities and Limitations of ACUT2E
A bright-blood turbo spin-echo steadystate free precession hybrid (ACUT2E) sequence has been developed and tested in comparison with T2-weighted STIR and has been found to have lower inter-and intraobserver variability on a single image set following STEMI (25) . ACUT2E overcomes artifacts such as posterior wall signal loss due to cardiac motion and bright-blood subendocardial rims due to stagnant blood.
In keeping with our results (identification of IRA), the results in previous studies have suggested that brightblood imaging has a higher diagnostic accuracy than does T2-weighted STIR. Payne et al (25) demonstrated an increased diagnostic accuracy of the bright-blood ACUT2E sequence compared with T2-weighted STIR. In our study, although the diagnostic accuracy (detection of IRA) of ACUT2E was better than that of T2-weighted STIR, it was significantly worse than that of both T2 mapping and EGE and presented a high intraobserver and interimage variability. This is most likely due to lower contrast-to-noise ratio, resulting in blurring of the contours between normal and abnormal myocardium.
Opportunities and Limitations of EGE
The researchers in a recent study have proposed that performing imaging 2 minutes following gadolinium-based contrast agent administration (EGE) could delineate myocardial edema rather than the infarcted tissue (9) . The basis for this is the alterations in gadoliniumbased contrast agent kinetics following acute myocardial infarction (28) . This study (9) showed a good correlation with myocardial edema detected by using T2-weighted STIR. The administration of contrast agent can improve image quality by sharpening the contours between normal and abnormal myocardium. This explains the low intra-and interobserver variability. However, our results also show that this sequence had the highest interimage variability. This can be explained by the intricacies of gadolinium-based contrast agent kinetics and the fact that imaging took place between 1 and 3 minutes after contrast agent injection. The optimal timing to acquisition of EGE images following STEMI has not yet been completely validated (29) . From our study, it also appeared that the size of myocardial edema was significantly smaller, as measured with this method, when compared with that of the other three sequences. This difference, again, can be explained with the dynamic contrast agent kinetics intrinsic to this sequence (30). Given the limited evidence, further work is needed to validate this technique in clinical practice.
Opportunities and Limitations of T2 Mapping A T2 mapping sequence (7) has been proposed. Direct estimation of myocardial T2 value can be extrapolated from these images (12) , compared with the other T2 sequences, and it provides potentially attractive quantitative parameters to be used in studies. In a previous validation study, this T2 mapping sequence appeared to be superior to T2-weighted STIR (12) . A T2 mapping sequence overcomes some of the limitations of T2-weighted STIR. Our study results confirm what was previously observed by Verhaert et al (12) that T2 mapping is a robust quantitative method for assessing myocardial edema following STEMI compared with T2-weighted STIR. To our knowledge, there have been no head-to-head comparisons between T2 mapping and bright-blood sequences. In our study, this was the only sequence with consistently low variability for all interobserver, intraobserver, and interimage readings. Both T2 mapping and EGE consistently provide interpretable images and good image quality when compared with T2-weighted STIR and ACUT2E. T2 mapping and EGE were also the most reliable methods to help correctly identify the IRA.
Despite the observers having significantly more experience with T2-weighted STIR than with ACUT2E, T2 mapping, and EGE, the interobserver variability was lower in the latter three sequences compared with T2-weighted STIR. T2 mapping has the lowest interobserver variability, and therefore, may be potentially less user dependent with a smaller learning curve.
Study Limitations
Given the clinical nature of the study, an intrinsic limitation is the lack of histologic validation. Despite T2-weighted STIR having the limitations described above, T2-weighted STIR was used as the current reference standard for myocardial edema mass comparison, as this sequence has the most evidence behind its use and, more important, has prognostic data (6, 15, 16) . In absolute terms, the reference standard to use would have been histologic examination, but in the setting of a human clinical study, as ours, this option would not have been possible. A more complete validation of these sequences could have been performed with animal studies, but this option was outside the purpose of the current study. However, human studies are important despite this lack of histologic findings, as it has been shown that infarct evolution differs according to species for time to reperfusion following myocardial infarction (31). Currently, although there are proposed semiautomatic methods for T2-weighted STIR analysis (32), a standardized method for analyzing for T2-weighted STIR, T2 mapping, and ACUT2E images is not available (33). Also, the 5-SD or full width at half maximum methods (14) proposed for contrast material-enhanced images (ie, late myocardial enhancement) are not validated and do not necessarily apply to the EGE method. T1 mapping may have the potential to detect edema (34) but it has not yet been substantially studied in reperfused infarction.
Conclusion
The results of this study demonstrate that T2 mapping is the most reproducible method for assessing myocardial edema following reperfused STEMI, with the lowest variability. The results of this study should be taken into consideration when designing trials in which myocardial edema or myocardial salvage is used as an end point.
